Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "PATH"

1239 News Found

Ministry of Ayush to organise two-day convention on World Homeopathy day
News | April 09, 2022

Ministry of Ayush to organise two-day convention on World Homeopathy day

World Homoeopathy Day is observed to commemorate the birth anniversary of the founder of Homoeopathy, Dr. Christian Fredrich Samuel Hahnemann to mark his 267th birth anniversary


Dr Lal PathLabs to use drones for sample collection and diagnostic access
Clinical Trials | April 05, 2022

Dr Lal PathLabs to use drones for sample collection and diagnostic access

Pilots to be launched across multiple locations in India.


Tarlige tablets approved in Japan for treatment of patients with neuropathic pain
Drug Approval | March 28, 2022

Tarlige tablets approved in Japan for treatment of patients with neuropathic pain

In May 2021, Daiichi Sankyo had submitted a supplemental new drug application (sNDA) for Tarlige tablets based on results from a phase 3 trial in patients with CNP


Illumina unveils pathbreaking genomic profiling test for cancer in Europe
Medical Device | March 15, 2022

Illumina unveils pathbreaking genomic profiling test for cancer in Europe

The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey


USFDA grants Breakthrough Therapy Designation for Idiopathic Pulmonary Fibrosis therapy
Biotech | February 25, 2022

USFDA grants Breakthrough Therapy Designation for Idiopathic Pulmonary Fibrosis therapy

Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases


AMPATH launches its pathology laboratory in Mumbai
Clinical Trials | November 29, 2021

AMPATH launches its pathology laboratory in Mumbai

The company has has 10 existing labs in India


Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore
Clinical Trials | October 27, 2021

Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore

Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21


QMS Medical partners with ZEISS for screening diabetic retinopathy
Medical Device | September 27, 2021

QMS Medical partners with ZEISS for screening diabetic retinopathy

Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes


U.S. FDA approves Repatha for paediatric patients aged 10 years and older
Drug Approval | September 27, 2021

U.S. FDA approves Repatha for paediatric patients aged 10 years and older

The FDA also approved Repatha as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia (HoFH) for younger pediatric patients


Xybion releases Pristima XD digital pathology
Digitisation | August 24, 2021

Xybion releases Pristima XD digital pathology

The module offers the first preclinical laboratory information system of its kind that is fully integrated into the digital pathology workflow and provides efficient pathological studies of whole slides